Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2013 |
Pulmonary function
|
phenotype |
|
Organ or Tissue Function
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Fatty acid measurement
|
group |
|
Laboratory Procedure
|
50
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Pulmonary function (finding)
|
phenotype |
|
Finding
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Lysosomal Storage Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
130
|
8
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2003 |
Neuronal Ceroid-Lipofuscinoses
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
51
|
74
|
0.220 |
None |
1.000 |
2 |
|
2003 |
2005 |
Infantile neuronal ceroid lipofuscinosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
22
|
4
|
0.020 |
None |
0.500 |
2 |
|
1999 |
2003 |
Membranous glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
197
|
33
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Histiocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Histiocytic syndrome
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
21
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.100 |
None |
1.000 |
1 |
2
|
2007 |
2007 |
Birth Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
214
|
369
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Muscle Spasticity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
580
|
48
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Ataxia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
868
|
68
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Cerebellar Ataxia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
441
|
120
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Pulmonary Emphysema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
352
|
64
|
0.110 |
None |
1.000 |
1 |
1
|
2014 |
2014 |